We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 121-134 of 134 results
  1. Molecular Therapies for Malignant Gliomas

    Due to the dismal prognosis of malignant glioma patients there is an urgent need for new innovative treatments based on a better understanding of the...
    Markus Hutterer, Günther Stockhammer in Therapeutic Ribonucleic Acids in Brain Tumors
    Chapter 2009
  2. Molecularly Targeted Therapies for Malignant Gliomas

    This review critically evaluates current knowledge of molecularly targeted therapies of malignant gliomas. Various molecularly targeted single-agent...

    Andreas A. Argyriou, Haralabos P. Kalofonos in Molecular Medicine
    Article Open access 01 March 2009
  3. Current Clinical Management of Metastatic Lung Cancer

    Approximately 40% of patients with non-small cell lung cancer (NSCLC) and 70% of patients with small cell lung cancer (SCLC) present with advanced,...
    Bryan J. Schneider, Suresh S. Ramalingam in Lung Cancer Metastasis
    Chapter 2009
  4. Molecular targeting of Bcl-2 overcomes prostate cancer cell adaptation to XIAP gene downregulation

    X-linked inhibitor of apoptosis (XIAP) is a suppressor of apoptosis that supports an increased survival and resistance to chemotherapy of human...

    Y Nakano, V Bilim, ... Y Tomita in Prostate Cancer and Prostatic Diseases
    Article 13 May 2008
  5. Cancer is a Preventable Disease that Requires Major Lifestyle Changes

    This year, more than 1 million Americans and more than 10 million people worldwide are expected to be diagnosed with cancer, a disease commonly...

    Preetha Anand, Ajaikumar B. Kunnumakara, ... Bharat B. Aggarwal in Pharmaceutical Research
    Article Open access 15 July 2008
  6. RNA Interference (RNAi) – siRNA

    Arndt Borkhardt, Astrid Novosel in Encyclopedia of Molecular Pharmacology
    Reference work entry 2008
  7. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor

    Osteosarcoma is major cause of cancer-related death in the pediatric age group, and this is due to the development of pulmonary metastases that fail...

    Eugene T. H. Ek, Crispin R. Dass, ... Peter F. M. Choong in Clinical & Experimental Metastasis
    Article 18 April 2007
  8. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases

    The polyamines spermidine and spermine and their diamine precursor putrescine are naturally occurring, polycationic alkylamines that are essential...

    Robert A. Casero Jr, Laurence J. Marton in Nature Reviews Drug Discovery
    Article 01 May 2007
  9. Current development of mTOR inhibitors as anticancer agents

    Mammalian target of rapamycin (mTOR) is a kinase that functions as a master switch between catabolic and anabolic metabolism and as such is a target...

    Sandrine Faivre, Guido Kroemer, Eric Raymond in Nature Reviews Drug Discovery
    Article 01 August 2006
  10. Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication

    We evaluated a new approach to AIDS therapy by using combinations of oligodeoxynucleotides (ODNs), delivered with a lipid-based carrier system, that...

    Carole Lavigne, Jocelyn Yelle, ... Alain R. Thierry in AAPS PharmSci
    Article 01 March 2001
  11. NPY Y5 Receptor Subtype

    Neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) are endogenous 36-amino acid peptides belonging to the same family. Different...
    Andrea O. Schaffhauser, Alain Stricker-Krongrad, Karl G. Hofbauer in Neuropeptide Y Protocols
    Protocol 2000
  12. Gene Therapy Strategies for Inhibition of HIV

    Most of the HIV proteins and virtually every stage in the HIV life cycle can be viewed as a potential site for inhibition. Several of the HIV...
    Magnús Gottfredsson in Gene Therapy for HIV Infection
    Chapter 1998
Did you find what you were looking for? Share feedback.